SA

Sayeed Ahmad Usmani

Active Director Director DIN 08239507
DIN 08239507 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Sayeed Ahmad Usmani

Data last updated:

Sayeed Ahmad Usmani is a Director at Sarosh Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Sarosh Pharmaceuticals Private Limited reported revenue of ₹30 Lakh (FY 2025).

DIN 08239507
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2018
Oldest Company Age 8 yrs
Largest company Sarosh Pharmaceuticals Private Limited · ₹30 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Sep 20182018₹30 Lakh (FY 2025)Active

Board colleagues of Sayeed Ahmad Usmani

Directorship timeline

Open interactive timeline →
Sarosh Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sayeed Ahmad Usmani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayeed Ahmad Usmani

Sayeed Ahmad Usmani currently holds 1 directorship: Sarosh Pharmaceuticals Private Limited (Director, since 26 Sep 2018, revenue ₹30 Lakh (FY 2025)).

Sayeed Ahmad Usmani was first appointed on 26 Sep 2018 as Director at Sarosh Pharmaceuticals Private Limited.

The current boards of Sayeed Ahmad Usmani's companies include Abdul Hafeez Farooqui (Sarosh Pharmaceuticals Private Limited), Zikra Khan (Sarosh Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available